GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Semler Scientific Inc (NAS:SMLR) » Definitions » Cash-to-Debt

Semler Scientific (Semler Scientific) Cash-to-Debt : 454.74 (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Semler Scientific Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Semler Scientific's cash to debt ratio for the quarter that ended in Mar. 2024 was 454.74.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Semler Scientific could pay off its debt using the cash in hand for the quarter that ended in Mar. 2024.

The historical rank and industry rank for Semler Scientific's Cash-to-Debt or its related term are showing as below:

SMLR' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.06   Med: 173.53   Max: No Debt
Current: 454.74

During the past 13 years, Semler Scientific's highest Cash to Debt Ratio was No Debt. The lowest was 0.06. And the median was 173.53.

SMLR's Cash-to-Debt is ranked better than
91.9% of 864 companies
in the Medical Devices & Instruments industry
Industry Median: 1.875 vs SMLR: 454.74

Semler Scientific Cash-to-Debt Historical Data

The historical data trend for Semler Scientific's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Semler Scientific Cash-to-Debt Chart

Semler Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash-to-Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only No Debt No Debt 114.84 175.87 357.50

Semler Scientific Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 191.82 255.30 309.54 357.50 454.74

Competitive Comparison of Semler Scientific's Cash-to-Debt

For the Medical Devices subindustry, Semler Scientific's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Semler Scientific's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Semler Scientific's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Semler Scientific's Cash-to-Debt falls into.



Semler Scientific Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Semler Scientific's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Semler Scientific's Cash to Debt Ratio for the quarter that ended in Mar. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Semler Scientific  (NAS:SMLR) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Semler Scientific Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Semler Scientific's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Semler Scientific (Semler Scientific) Business Description

Traded in Other Exchanges
Address
2340-2348 Walsh Avenue, Suite 2344, Santa Clara, CA, USA, 95051
Semler Scientific Inc is a US-based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test.
Executives
Eric Semler director 4625 FIELDSTON ROAD, BRONX NY 10471
Renae Cormier officer: Chief Financial Officer C/O SEMLER SCIENTIFIC, INC., 2340-2348 WALSH AVE, SUITE 2344, SANTA CLARA CA 95051
Douglas Murphy-chutorian director, 10 percent owner, officer: Chief Executive Officer C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, SUITE 110, SAN JOSE CA 95112
Wayne T Pan director 2330 NW EVERETT STREET, PORTLAND OR 97210
William H.c. Chang & Diana Shon Chang Ttee Chang Family Trust U/a Dtd 10/23/2006 10 percent owner C/O SEMLER SCIENTIFIC, INC., 911 BERN CT., SAN JOSE CA 95112
Chang 2020 Delaware Lp 10 percent owner C/O SEMLER SCIENTIFIC, INC., 2340-2348 WALSH AVENUE, SUITE 2344, SANTA CLARA CA 95051
Arthur N Leibowitz director C/O I-TRAX INC, ONE LOGAN SQUARE STE 2615, PHILADELPHIA PA 19103
Chang 2020 Gp Llc 10 percent owner C/O SEMLER SCIENTIFIC, INC., 2340-2348 WALSH AVENUE, STE. 2344, SANTA CLARA CA 95051
Cindy Moon director C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, SAN JOSE CA 95112
Daniel S Messina director C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, STE. 110, SAN JOSE Z4 95112
Daniel E Conger officer: Vice President, Finance C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, SUITE 110, SAN JOSE CA 95112
William H Chang 10 percent owner C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, SUITE 110, SAN JOSE CA 95112
Diana Shon Chang 10 percent owner 1301 SHOREWAY RD., SUITE 150, BELMONT CA 94002
Andrew B. Weinstein officer: Senior VP, Finance and Acct. C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, SUITE 110, SAN JOSE CA 95112
Herbert J Semler director, 10 percent owner C/O SEMLER SCIENTIFIC, INC., 2330 NW EVERETT ST., PORTLAND OR 97210